Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
09/2005
09/21/2005CN1671714A Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
09/21/2005CN1671712A 1, 2-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/21/2005CN1671386A Substituted anilinic piperidines as MCH selective antagonists
09/21/2005CN1219511C Method for curing sepsis
09/20/2005US6946478 Compounds
09/20/2005US6946473 4-((4-But-2-ynyloxy-benzenesulfonyl)-methyl-amino)-1,3-dimethy l-1H- pyrazolo(3,4-b)and dericatives; bioavailability; no pharmacokinetic problems; bioselectiveity; rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis
09/15/2005WO2005085275A1 Inhibitors of hepatitis c virus ns3 protease
09/15/2005WO2005085256A1 Isopropanol water solvate of olanzapine
09/15/2005WO2005085234A2 Bycyclic anthranilamide derivatives useful as insecticides
09/15/2005WO2005085194A2 Indole-2-carboxylic acid hydrazides as glycogen phosphorylase inhibitors
09/15/2005WO2005085176A1 π-CONJUGATED AROMATIC RING-CONTAINING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE
09/15/2005WO2005054198A3 Therapeutics use of pyridinium compounds to modulate naadp activity
09/15/2005WO2005049589A3 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases
09/15/2005US20050203296 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
09/15/2005US20050203122 Benzenesulfonic acid salts of clopidogrel, methods for preparing same, and pharmaceutical formulations thereof
09/15/2005US20050203118 Rheumatic diseases; antiarthritic agents; multiple sclerosis; antidiabetic agents; asthma therapy; skin disorders
09/15/2005US20050203092 4-Pyrimidinamine derivatives, pharmaceutical compositions and related methods
09/15/2005US20050203081 Inhibitors of protein tyrosine phosphatase 1B
09/15/2005CA2557986A1 Isopropanol water solvate of olanzapine
09/15/2005CA2557322A1 Inhibitors of hepatitis c virus ns3 protease
09/15/2005CA2556387A1 Bicyclic anthranilamide derivatives useful as insecticides
09/15/2005CA2549705A1 Switchable window based on electrochromic polymers
09/14/2005EP1573391A2 Second order nonlinear optical chromophores, polymers containing same, and electro-optic devices therefrom
09/14/2005EP1572698A1 3-substituted 3,4-dihydro-thieno[2,3-d]pyrimidine-4-one-derivatives, production and use thereof
09/14/2005EP1572659A2 The use of 4-phenyl substituted tetrahydroisoquinolines in the treatment of pain, migraine and urinary incontinence
09/14/2005EP1499609A4 Pesticidal heterocycles
09/14/2005EP1404682B1 Method of inhibiting ptp 1b and/or t-cell ptp and/or other ptpases with an asp residue at position 48
09/14/2005CN1668622A 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
09/14/2005CN1668601A N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors
09/14/2005CN1668307A New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2, 3-d]pyrimidine
09/13/2005US6943275 carbondisulfide or a dialkyl trithiocarbonate and an alkylating agent (R'X); Grignard reagent in the presence of a copper catalyst, lithium tetrachlorocuprate Li2CuCl4; conjugated polymer and copolymer precursors
09/13/2005US6943189 mixture of sulfur compounds and 3-hydroxy-3-methylglutaryl-coenzyme A inhibitors, used for prophylaxis of hyperlipemia in mammals
09/13/2005US6943186 Administering benzopyrazolyl compound for therapy of sepsis
09/13/2005US6943175 Nitrogen compounds such as N-(3,5-dibromobenzyl)-N'-(1H-imidazo[4,5-b]pyridin-2-yl)-propane-1,3-diamine, used as inhibitors of methionyl transfer RNA synthetases in bacteria; antibiotics; bactericides
09/09/2005WO2005082887A1 Pyrimidine derivative
09/09/2005WO2005082865A1 Fused bicyclic pyrimidine derivative
09/09/2005WO2005081960A2 Inhibitors of protein tyrosine phosphatase 1b
09/09/2005CA2557541A1 Pyrimidine derivatives
09/08/2005US20050198462 Charge transfer complexes including an electron donor and an electron acceptor as basis of resistive memories
09/08/2005US20050197380 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
09/08/2005US20050197371 Urea derivatives as PDGFR modulators
09/07/2005EP1569942A2 Tricyclic aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
09/07/2005EP1569941A1 Anthelmintic and insecticidal thiohene compositions
09/07/2005EP1569938A1 Method of making tricyclic aminocyanopyridine compounds
09/07/2005EP1569935A1 Heterocyclic compounds, preparation method thereof and use of same as medicaments, such as anti-bacterial medicaments and beta-lactamase inhibitors
09/07/2005EP1569932A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
09/07/2005CN1665821A 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/07/2005CN1665808A Thiadiazoles or oxadiazoles and their use as inhibitors of JAK protein kinase
09/07/2005CN1665806A Medicine compound
09/07/2005CN1665800A Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
09/07/2005CN1665513A 1, 3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/06/2005US6939888 Heterocyclic amides such as 3-(2-chloro-6-methoxyphenyl)-5-isopropyl-5-methyl-4-acetoxy-3-pyrrolidine-2 -one, used as insecticides or miticides
09/01/2005WO2005080890A1 Pharmacologically acceptable salts of clopidogrel
09/01/2005WO2005080401A1 Process for the preparation of olanzapine form 1 useful as antipsychotic drug
09/01/2005WO2005080400A1 Chemical compounds
09/01/2005WO2005080382A1 Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
09/01/2005WO2005080378A1 Fused pyridazine derivatives
09/01/2005WO2005080377A1 COMPOUND HAVING TGF-β INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
09/01/2005WO2005080339A1 Sulfonyloxy derivatives
09/01/2005WO2005037271A3 Large conductance calcium-activated k channel opener
09/01/2005WO2003101941A3 Alpha acyloxyacetamides for kallikrein and urokinase inhibition
09/01/2005US20050192418 Heterocyclic metallocenes and polymerization catalysts
09/01/2005US20050192334 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
09/01/2005US20050192333 Spirocyclic cyclohexane compounds
09/01/2005US20050192332 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same
09/01/2005US20050192314 Use of urea derivatives of isoxazoles; c-kit kinase inhibitors; anticancer agents; leukemias such as acute myelogenous leukemia (AML), and chronic myelogenous leukemias (CMLs)
09/01/2005US20050192313 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder
09/01/2005US20050192253 For treating cancer, cardiovascular, sexual and immune disorders; 3a alpha ,4 beta ,5 alpha ,7 beta ,7a alpha )-4-(Octahydro-5- ethylsulfonamido-4,7-dimethyl-1,3-dioxo-4,7-epoxy-2H-isoindol-2-yl)-2- (trifluoromethyl)benzonitrile
09/01/2005CA2557537A1 Sulfonyloxy derivatives
09/01/2005CA2557256A1 Pharmacologically acceptable salts of clopidogrel
08/2005
08/31/2005EP1567501A1 Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors
08/31/2005EP1129087B1 Process for racemization
08/31/2005EP0888333B1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
08/31/2005CN1662543A Process for the preparation of olanzapine and an intermediate therefor
08/31/2005CN1662539A [1, 4]diazocino [7, 8, 1-hi]indole derivatives as antipsychotic and antiobesity agents
08/31/2005CN1662521A Compounds useful for the treatment of obesity, type ii diabetes and cns disorders
08/31/2005CN1660849A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/31/2005CN1660839A Chemical compounds
08/31/2005CN1660815A Cyclic amine derivatives and their use as drugs
08/30/2005US6936700 Radiolabeled chelation compounds used in pharmaceuticals for diagnostic and therapeutic purposes
08/30/2005US6936189 Cyclic tertiary amine compound and organic electroluminescent device containing the compound
08/25/2005WO2005077967A1 Radiolabeled compounds and compositions, their precursors and methods for their production
08/25/2005WO2005077958A1 Resolution of racemates of methyl alpha-5-[4,5,6,7-tetrahydro[3,2-c]thienopyridyl]-(2-chlorophenyl)acetate
08/25/2005WO2005077943A1 1 , 3 - dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes
08/25/2005WO2005076861A2 Compounds that inhibit hiv particle formation
08/25/2005WO2005023818A3 Heterobicyclic compounds as pharmaceutically active agents
08/25/2005US20050187282 Condensed indoline derivatives and their use as 5HT, in particular 5HT2c, receptor ligands
08/25/2005US20050187281 Spirocyclic cyclohexane derivatives
08/25/2005US20050187257 Methods of treating sepsis
08/25/2005US20050187217 Sodium channel modulators; pain relievers; treating epilepsy, neurodegenerative disorders, psychiatric disorders, arrhythmia, movement disorders, autoimmune diseases, and incontinence; fused ring 4-aminopyrimidines e.g. 4-amino-5,6,7,8-tetrahydroquinazolines
08/25/2005US20050187209 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors
08/25/2005DE102004005785A1 2-Halogenfuryl/thienyl-3-carboxamide 2-Halogenfuryl / thienyl-3-carboxamides
08/25/2005CA2555817A1 1 , 3 - dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes
08/25/2005CA2555597A1 Radiolabeled compounds and compositions, their precursors and methods for their production
08/25/2005CA2555132A1 Compounds that inhibit hiv particle formation
08/24/2005EP1565474A2 Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
08/24/2005EP1565443A2 Acetyl 2-hydroxy-1,3 diaminoalkanes
08/24/2005EP1565436A2 3-aminopyrrolidine derivatives as modulators of chemokine receptors
08/24/2005EP1353927B1 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
08/24/2005EP1019075B1 Beta 2-adrenergic receptor agonists
1 ... 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 ... 214